Has Stephen Brassell, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,592 in general payments to Stephen Brassell, MD across 26 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephen Brassell, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephen Brassell, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephen Brassell, MD

Urology · Boise, IDNPI 1538108311

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by EDAP Technomed Inc at 43.5% of the total. Reporting peaked in 2024 at $1,355 and has fallen 78.1% since, to $297 in 2025. That places this record below the midpoint for urology clinicians in ID, where the typical reported total is $3,075.

$2,592in general payments, 2019–2025

Across 26 payments — averaging $99.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

EDAP Technomed Inc$1K
Intuitive Surgical$620
Urogen Pharma, Inc.$282
Johnson & Johnson$198
Ferring Pharmaceuticals Inc.$131
Bayer$129
plus $103 from 4 others

$20,904in research payments, 2019–2025

Across 11 payments — averaging $1900.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sumitomo Pharma America, Inc.$21K

What the payments were for

Food & beverage$2,54998%
Education$422%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
EDAP Technomed Inc	7	$1,128
Intuitive Surgical	8	$620
Urogen Pharma, Inc.	3	$282
Johnson & Johnson	2	$198
Ferring Pharmaceuticals Inc.	1	$131
Bayer	1	$129
Procept Biorobotics Corporation	1	$45
Stimwave Technologies Incorporated	1	$39
Olympus America Inc.	1	$15
Travere Therapeutics, Inc.	1	$4

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,592 in reported general payments places this provider in the 35th percentile of 55 urology providers in Idaho.

See all urology providers in Idaho →

Medicare billing

Part B allowed, 2024

$179,128

Medicare patients

520

Services billed

1,960

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	227	$3,261
Finasteride	255	$3,246
Trospium Chloride	11	$1,201
Cefdinir	13	$382
Alfuzosin Hcl ErAlfuzosin Hcl	11	$301
Oxybutynin Chloride	36	$274
Levofloxacin	92	$169
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	25	$130
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	17	$103
Diazepam	74	$64
Tramadol Hcl	20	$55

Paid to pharmacies, not to this prescriber.

Other urology in Boise

Sean StroupBoise$93K
Robert JacksonBoise$7K
Kenneth VerlageBoise$5K
Kara TaggartBoise$273
Zachary GlaserTwin Falls$15K
Wade MunceyMeridian$9K
John GreerMeridian$8K
Dawn KingMeridian$8K
Chad PetersonCoeur D Alene$7K
Edward EllisonCoeur D' Alene$7K

See the full list for Idaho →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →